All News
Hemophagocytic Syndrome in Adults
Hemophagocytic lymphohistiocytosis(HLH) is a rare complication of many disorders. In children, systemic JIA is by far the most common cause of HLH.
Read Article
Celebrex Goes Generic
The generic drug manufactuer Actavis joins Teva and Mylan with their lauch of celecoxib (Celebrex)in 50 mg, 100 mg, 200 mg and 400 mg capsules. In 2013 celecoxib was the 21st leading prescribed drug in the U.S. with $2.4 billion in sales as of mid 2014.
Read Article
Night-time Gout Onset is Not Related to Alcohol or Purine Intake
Gout's often told tale of a nocturnal rapid onset and dramatic pain provoked by a bed sheet, is studied in detail by Choi and the Boston online gout study. This report shows that more than half the attacks occur late night and are unrelated to alcohol or purine intake.
Read ArticleWait a minute: how much to develop a new drug?
Older estimates suggested it would cost $1 billion to develop a new drug. ThisNY Times article discusses newer estimates claiming it cost 2.6 billion to bring a new drug to market.
Read ArticleGeneric drug prices soar
Congress investigates why the price of more than 1,200 generic medications increased an average 448% betweeen 2013-2014.http://buff.ly/1v56VUt
Read ArticlePregnant women getting better drug safety information
WASHINGTON - Pregnant women are about to get easier-to-understand information on how safe their medicine is for baby.
Read ArticleNobel Prize goes for $4.8 million at auction
Dr James Watson, of Watson and Crick double-stranded DNA fame, has offered up his Nobel prize for auction, with the intention of donating the proceeds to medical institutions which he says has nurtured him, and scores of others, during his career.
Read ArticleSpecialty Drugs to Cost Consumers More Next Year
The patients out of pocket costs for "Specialty Drugs" will increase significantly in 2015.
Read ArticleNIH Accelerating Medicines Partnership has awarded 10 US centers grants to study Rheumatoid Arthritis and Lupus
In September 2014, the participating members of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Program funded a research Network to implement the program.
Read Article
Turmeric vs. Ibuprofen: Which is Better for Arthritis?
Ibuprofen has a corner on the over-the-counter pain market, accounting for one-third of OTC analgesics in the U.S.
Read Article
Dynamic Duo Takes Out The Cellular Trash
Salk scientists identify how immune cells use two critical receptors to clear dead cells from the body, pointing the way to new autoimmune and cancer therapies.
Read ArticleRoActemra wins EU approval for early RA
Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis.
Read ArticleThe Safety of Restarting Infliximab After a Long Drug-Free Hiatus
Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological
Read Article